Загрузка...
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
Onconase is a ribonuclease that presents both antitumor and antiviral properties linked to its ribonucleolytic activity and represents a new class of RNA-damaging drugs. It has reached clinical trials for the treatment of several cancers and human papilloma virus warts. Onconase targets different RN...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5355296/ https://ncbi.nlm.nih.gov/pubmed/28035074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14302 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|